Brief: Argenx Q2 Net Income USD 245.358 Million
31/07/2025 06:00
Jul 31 (Reuters) - Argenx Q2 total operating income USD 967.187 million. Q2 basic EPS USD 4.02 Q2 EPS USD 3.74 Q2 operating expenses USD -766.126 million
Recent news on argenx SE
See all newsArgenx falls after Vyvgart trial update on myositis drug, brokers remain positive
Brief: ArgenX Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit In Myositis And Sjogren’S Disease
Brief: argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
Brief: Argenx Q1 Total Operating Income USD 1.313 Bln
Netherlands' Argenx Q1 net sales rise 63%, profit more than doubles